Effects of the novel protein kinase C inhibitor AEB071 (Sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720-Reference-Cited by-同舟云学术

Effects of the novel protein kinase C inhibitor AEB071 (Sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720

Published:2009-12-09 Issue:5 Volume:23 Page:543-552
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:

Author:

Weckbecker Gisbert,Pally Charles,Beerli Christian,Burkhart Christoph,Wieczorek Grazyna,Metzler Barbara,Morris Randall E.,Wagner Juergen,Bruns Christian

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1432-2277.2009.01015.x/fullpdf

Reference32 articles.

1. Immunosuppressive drugs for kidney transplantation;Halloran;N Engl J Med,2004

2. Organ Transplantation - how much of the promise has been realized?;Lechler;Nat Med,2005

3. Cells mediating allograft rejection;Hall;Transplantation,1991

4. Signal transduction by the TCR for antigen;Kane;Curr Opin Urol,2000

5. PKC at a glance;Parker;J Cell Science,2004

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Targets of Immunosuppression in Transplantation;Clinics in Laboratory Medicine;2019-03

2. Discovery of 2,4-diamino-5-cyanopyrimidine derivatives as protein kinase C theta inhibitors with mitigated time-dependent drug-drug interactions;Bioorganic & Medicinal Chemistry;2019-03

3. A novel 2,4-diaminopyrimidine derivative as selective inhibitor of protein kinase C theta prevents allograft rejection in a rat heart transplant model;Bioorganic & Medicinal Chemistry;2018-11

4. Emerging drugs for prevention of T-cell mediated rejection in liver and kidney transplantation;Expert Opinion on Emerging Drugs;2017-04-03

5. Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy;Immunological Reviews;2017-03